Concepedia

Patrick Mayo

PM

17

Publications

536

Citations

13

H-Index

1987

Active since

Affiliations

University of Alberta(Current)

Alberta Hospital Edmonton

University of Alberta Hospital

Edison Pharmaceuticals (United States)

Scripps Research Institute

Patrick Mayo is an author at University of Alberta specializing in medicine, pharmacology, and nephrology.

ORCID

Top concepts

Publications per year

1987–2022

17

Publications

17

Decreased dromotropic response to verapamil despite pronounced increased drug concentration in rheumatoid arthritis

Patrick Mayo, Kenneth J. Skeith, Anthony S. Russell et al. · British Journal of Clinical Pharmacology · 2000 · 127 citations · Full text

Pain management in chronic kidney disease: the pharmacokinetics and pharmacodynamics of hydromorphone and hydromorphone-3-glucuronide in hemodialysis patients.

Sara N. Davison, Patrick Mayo · PubMed · 2009 · 59 citations

A randomized, multicenter, double-blind, placebo-controlled phase 2 trial of ISA247 in patients with chronic plaque psoriasis

Robert Bissonnette, Kim Papp, Yves Poulin et al. · Journal of the American Academy of Dermatology · 2006 · 56 citations

, , +4

A Pan-Cyclophilin Inhibitor, CRV431, Decreases Fibrosis and Tumor Development in Chronic Liver Disease Models

Joseph Kuo, Michael Bobardt, Udayan Chatterji et al. · Journal of Pharmacology and Experimental Therapeutics · 2019 · 51 citations · Full text

Effect of Passive Smoking on Theophylline Clearance in Children

Patrick Mayo · Therapeutic Drug Monitoring · 2001 · 27 citations

, , +15

Rows per page

1–5 of 17